{
  "url": "https://openlegislation.uk/eu-regulation-2020-1685/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2020-1685/annex.json",
  "legislation": "eur/2020/1685",
  "legislation_title": "Commission Implementing Regulation (EU) 2020/1685 of 12 November 2020 amending Regulation (EU) No 37/2010 to classify the substance bupivacaine as regards its maximum residue limit (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2020-1685",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:\nPharmacologically active Substance\nMarker residue\nAnimal Species\nMRLs\nTarget Tissues\nOther Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)\nTherapeutic Classification\n‘Bupivacaine\nNOT APPLICABLE\nPorcine\nNo MRL required\nNOT APPLICABLE\nFor use in piglets up to 7 days of age only.\nFor cutaneous and epilesional use only.\nLocal anaesthetic’\nBovine\nFor use in calves up to 2 months of age only.\nFor cutaneous and epilesional use only.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2020/1685/annex",
    "retrieved_at": "2026-11-01T14:42:21.726755+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}